New allergy shot for mugwort pollen passes first safety test
NCT ID NCT07317960
First seen Jan 11, 2026 · Last updated May 06, 2026 · Updated 17 times
Summary
This early-stage trial tests whether a new vaccine called PollenVax is safe for people with moderate to severe mugwort pollen allergies. About 30 adults will receive either the vaccine or a placebo to check for side effects. The goal is to see if this approach can eventually ease seasonal allergy symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS DUE TO ARTEMISIA POLLEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Limited Liability Partnership "Medcenter-Rakhat"
Almaty, Almaty, 050000, Kazakhstan
Conditions
Explore the condition pages connected to this study.